United States · Venture startup

Who invested in Metaclipse Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2024, from 1 source

Latest round
VentureJun 2024
Investors
1
See who backed them

The rounds

  1. Jun 2024
    VentureAmount undisclosed

    Source recorded

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Metaclipse Therapeutics

Who invested in Metaclipse Therapeutics?

Metaclipse Therapeutics's investors include National Institutes of Health.

How much has Metaclipse Therapeutics raised?

Metaclipse Therapeutics has raised 1 round since 2024, none with a disclosed amount.

When did Metaclipse Therapeutics last raise?

Metaclipse Therapeutics's most recent round was a Venture in Jun 2024.

Who backed Metaclipse Therapeutics first?

Metaclipse Therapeutics's first round on record, in Jun 2024, was backed by National Institutes of Health.

What stage is Metaclipse Therapeutics at?

Metaclipse Therapeutics's latest named round is a Venture, in Jun 2024.

Where is Metaclipse Therapeutics based?

Metaclipse Therapeutics is based in the United States.

Companies like Metaclipse Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.